- Accesswire•37 minutes ago
Upcoming AWS Coverage on AstraZeneca LONDON, UK / ACCESSWIRE / January 20, 2017 / Active Wall St. blog coverage looks at the headline from AbbVie Inc. (NYSE: ABBV ) as the Company announced on January ...
- Financial Times•20 hours ago
GlaxoSmithKline has poached its new global head of pharmaceuticals from rival AstraZeneca, marking a change of guard at Britain's biggest drugmaker as it prepares for the arrival of its new chief executive. ...
- Reuters - UK Focus•yesterday
LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief (Taiwan OTC: 3345.TWO - news) Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.
AZN: Summary for Astrazeneca PLC Common Stock - Yahoo Finance
AstraZeneca PLC (AZN)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
|Day's range||27.81 - 28.31|
|52-week range||25.55 - 35.04|
Trade prices are not sourced from all markets
|PE ratio (TTM)||31.90|
|Dividend & yield||0.90 (3.16%)|
|1y target est||N/A|